missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ VSIG1 Monoclonal Antibody (CT1), Biotin

Mouse Monoclonal Antibody

Brand:  Invitrogen™ MA528799

Product Code. 16343054

  • € 431.00 / 1mL

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

VSIG1 Monoclonal Antibody for Flow

VSIG1 encodes a member of the junctional adhesion molecule (JAM) family. The encoded protein contains multiple glycosylation sites at the N-terminal region, and multiple phosphorylation sites and glutamic acid/proline (EP) repeats at the C-terminal region. The gene is expressed in normal stomach and testis, as well as in gastric, esophageal and ovarian cancers. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

VSIG1
Monoclonal
0.5 mg/mL
PBS with proprietary stabilizer and <0.1% sodium azide; pH 7.4
Q9PWR4
VSIG1
Chicken thymocytes.
1 mL
Primary
Chicken, Avian
Antibody
IgG1 κ
Flow Cytometry
CT1
Biotin
VSIG1
1700062D20Rik; 4930405J24Rik; cell surface A33 antigen; CHT1; ChT1 thymocyte antigen; dJ889N15.1; Glycoprotein A34; GPA34; MGC44287; V-set and immunoglobulin domain containing 1; V-set and immunoglobulin domain-containing protein 1; Vsig1; VSIG1 protein
Mouse
Purified
RUO
414795
4°C
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.